PATENT CLAIM ANALYSIS

Application Number: 16308014
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-08
Patent Classification: ["424", "001890"]

Abstract:
The present invention addresses the problem of providing a technique for detecting a lesion of a heart disease in a non-invasive manner. The present invention provides a non-invasive diagnostic imaging agent for a heart disease, which contains a radioactively labeled compound capable of binding to an aldosterone synthase or a salt thereof as an active ingredient.

Claim (Index 23):
The non-invasive method according to  claim 13 , wherein the heart disease is a non-ischemic heart disease.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 98.0
- Lexical Diversity: 1.43902
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16211434', '15321972', '15543849', '14345493', '15543857']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7072854214187666
- 35 USC 102 Novelty (BERT): 0.5425463680448303
- Combined Prediction Score: 0.690811516081373
- Mean Citation Score: 255.15021399999995
- Max Citation Score: 341.4864
- Similarity Product: 134.02369735908508

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test